References
- Hassler L, Reyes F, Sparks M, Welling P, Batlle D. Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19. Clin J Am Soc Nephrol. 2021 Jun 14;
CJN.04560421 . doi: 10.2215/CJN.04560421 - Chan L, Chaudhary K, Saha A, et al. AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2021 Jan;32(1):151–160. doi: 10.1681/ASN.2020050615
- Pei G, Zhang Z, Peng J, et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020 Jun;31(6):1157–1165. doi: 10.1681/ASN.2020030276
- Lopes RD, Macedo AVS, de Barros ESPGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254–264. doi: 10.1001/jama.2020.25864
- Corbett RW, Blakey S, Nitsch D, et al. Epidemiology of COVID-19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020 Aug;31(8):1815–1823. doi: 10.1681/ASN.2020040534
- Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020 Dec;98(6):1530–1539. doi: 10.1016/j.kint.2020.07.030
- Azzi Y, Parides M, Alani O, et al. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int. 2020 Dec;98(6):1559–1567. doi: 10.1016/j.kint.2020.10.004
- Speer C, Goth D, Benning L, et al. Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2. Clin J Am Soc Nephrol. 2021 Jul;16(7):1073–1082. doi: 10.2215/CJN.03700321
- Yi SG, Knight RJ, Graviss EA, et al. Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration. Transplantation. 2021 Jul 1;105(7):e72–e73. doi: 10.1097/TP.0000000000003764
- Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 Jun 1;325(21):2204–2206. doi: 10.1001/jama.2021.7489
- Werbel WA, Boyarsky BJ, Ou MT, et al. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 Sep;174(9):1330–1332. doi: 10.7326/L21-0282
DOI: https://doi.org/10.14797/mdcvj.1058 | Journal eISSN: 1947-6108
Language: English
Page range: 91 - 93
Submitted on: Nov 3, 2021
Accepted on: Nov 3, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2021 Sean A. Hebert, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.